{"id":"NCT01992107","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old","officialTitle":"A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2013-11-25","resultsPosted":"2015-12-08","lastUpdate":"2015-12-08"},"enrollment":2333,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"QIVc","otherNames":[]},{"type":"BIOLOGICAL","name":"TIV1c","otherNames":[]},{"type":"BIOLOGICAL","name":"TIV2c","otherNames":[]}],"arms":[{"label":"QIVc (≥4 to <18 years)","type":"EXPERIMENTAL"},{"label":"TIV1c (≥4 to <18 years)","type":"ACTIVE_COMPARATOR"},{"label":"TIV2c (≥4 to <18 years)","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluate safety and immunogenicity of three influenza vaccines in children ages greater than 4 years old to less than 18 years old.","primaryOutcome":{"measure":"Geometric Mean Titre (GMT) in Subjects After Receiving One or Two Doses of Either QIVc, TIV1c or TIV2c","timeFrame":"Day 1,Three weeks post vaccination (Day 22 for previously vaccinated and Day 50 for Not previously vaccinated subjects)","effectByArm":[{"arm":"QIVc (≥4 to <18 Years)","deltaMin":96,"sd":null},{"arm":"TIV1c (≥4 to <18 Years)","deltaMin":100,"sd":null},{"arm":"TIV2c (≥4 to <18 Years)","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":88,"countries":["United States"]},"refs":{"pmids":["26585940"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":1149},"commonTop":["INJECTION SITE PAIN","INJECTION SITE ERYTHEMA","HEADACHE","INJECTION SITE INDURATION","FATIGUE"]}}